J. Bonafous

Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).

J. Michelot, Marie‐France Moreau, A. Veyre et al. · PubMed · 1993 · 119 citations

Medicine, Nuclear Medicine, Radiology +15

Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.

J. Michelot, Marie‐France Moreau, P.G. Labarre et al. · PubMed · 1991 · 89 citations

Medicine, Nuclear Medicine, Oncology +15

123 I- N -(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging

Nicole Moins, M. D’Incan, J. Bonafous et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 72 citations

Medicine, Oncology, Radiology +16

Early detection and monitoring of cartilage alteration in the experimental meniscectomised guinea pig model of osteoarthritis by 99mTc-NTP 15-5 scintigraphy

Elisabeth Miot-Noirault, Aurélien Vidal, Philippe Pastoureau et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 24 citations

Medicine, Nuclear Medicine, Orthopaedic Surgery +14

Clinical study of [¹²³I] N‐(2‐diethylaminoethyl)‐4‐ iodobenzamide in the diagnosis of primary and metastatic ocular melanoma

F Bacin, J. Michelot, J. Bonafous et al. · Acta Ophthalmologica Scandinavica · 1998 · 21 citations · Full text

Medicine, Nuclear Medicine, Oncology +17